As more research emerges on the therapeutic potential of cannabis, new findings are offering hope for patients and families affected by Alzheimer’s disease and dementia. A groundbreaking international study published in the Journal of Alzheimer’s Disease reports that patients with Alzheimer’s-related dementia experienced measurable cognitive improvements after sustained use of plant-derived cannabinoid extracts — marking one of the most promising developments in cannabis-based medicine to date.
Cannabis and Cognitive Function: What the Study Found
Researchers from Brazil and the United States conducted a 26-week placebo-controlled clinical trial involving 28 patients diagnosed with dementia associated with Alzheimer’s disease (AD). Participants were divided into two groups — one received a THC-CBD balanced cannabis extract, while the other received a placebo.
Throughout the study, patients’ cognitive function was measured at multiple intervals (baseline, 4, 8, 12, and 26 weeks).
- Those taking placebo experienced the expected decline in cognitive function common with Alzheimer’s progression.
- However, patients using cannabis extracts showed improved cognitive performance — with researchers describing these effects as “superior” to those seen with traditional Alzheimer’s medications.
Importantly, there were no significant differences in adverse events between the cannabis and placebo groups, suggesting the treatment was both safe and well-tolerated.
“We achieved with cannabis treatment remarkable disease stabilization in a half-year period,” the authors noted — a significant finding considering the rapid decline typical in Alzheimer’s disease.
Why It Matters for Georgia Patients
This study represents the longest clinical trial ever conducted evaluating cannabis’ effects on Alzheimer’s-related dementia. According to additional research published in the Journal of Psychopharmacology, cannabinoids may also help manage symptoms like agitation and aggression in dementia patients — offering a gentler alternative to traditional medications.
For Georgia residents, where medical cannabis is legal for qualified conditions through the state’s Low THC Oil Registry, these findings are particularly relevant. As more evidence supports cannabis’ role in cognitive health and symptom management, Georgians living with chronic or neurodegenerative conditions may benefit from exploring medical cannabis as part of their care plan.
A Compassionate, Evidence-Based Approach
At Elevated Health MD, our mission is to help Georgia patients access safe, physician-guided cannabis treatment options that fit their medical needs. Whether you or a loved one is living with Alzheimer’s disease, chronic pain, anxiety, or another qualifying condition, our licensed clinicians provide personalized care to help you navigate the state’s Low THC Oil program with confidence.
Take the Next Step
Medical cannabis isn’t just about symptom relief — it’s about improving quality of life.
If you believe cannabis may help you or a loved one, schedule your evaluation with Elevated Health MD today and apply for your 5-year Georgia medical cannabis card.
Start your path to better health — naturally, safely, and legally — with Elevated Health MD.
Leave a Reply